4.6 Review

Introduction into PPPM as a new paradigm of public health service: an integrative view

Journal

EPMA JOURNAL
Volume 3, Issue 1, Pages -

Publisher

SPRINGER INTERNATIONAL PUBLISHING AG
DOI: 10.1186/1878-5085-3-16

Keywords

Predictive; preventive; and personalised medicine; Subclinical; Omics; Bioinformatics; Biopredictors; Biomarkers; Ethics; Policy; Legacy; Economy; Integrative medical approach

Ask authors/readers for more resources

In the present state of healthcare, usual medical care is generally given to the already diseased person, while the key link-personal health monitoring underlain by predictive, preventive, and personalised medicine (PPPM) techniques that are being intensively elaborated worldwide-is simply missing. It is this link, based on the recognition of subclinical conditions, prediction, and further preventive measures, that is capable of regulating morbidity and diminishing the rates of disability among able-bodied population, thus significantly cutting the traditionally high costs of treating the already diseased people. To achieve the above-mentioned goal-the elaboration of the PPPM concept and its practical implementation-it is necessary to create a fundamentally new strategy based upon the subclinical recognition of the signs-bioindicators of cryptic abnormalities long before the disease clinically manifests itself. The implementation of PPPM programme requires an adjusted technology for the proper interpretation of diagnostic data, which would allow for the current 'physician-patient' model to be gradually replaced by a novel model, 'medical advisor-healthy men-at-risk'. This is the reason for an additional need in organising combinatorial scientific, clinical, training and educational projects in the area of PPPM to elicit the content of this new branch of medicine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

CRISPR-Cas systems for diagnosing infectious diseases

Anastasiya Kostyusheva, Sergey Brezgin, Yurii Babin, Irina Vasilyeva, Dieter Glebe, Dmitry Kostyushev, Vladimir Chulanov

Summary: This review focuses on the potential of CRISPR-based technologies to become platforms for point-of-care nucleic acid detection methods and deployable diagnostic platforms. Many Cas proteins have been utilized in the development of highly accurate and sensitive diagnostic tools, enabling fast, affordable, and user-friendly diagnostics.

METHODS (2022)

Article Medicine, Research & Experimental

May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases?

Sergey Batskikh, Sergey Morozov, Elena Vinnitskaya, Evgeniya Sbikina, Zanna Borunova, Alexey Dorofeev, Yulia Sandler, Kirill Saliev, Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, Vladimir Chulanov

Summary: The study found that a significant proportion of patients with autoimmune liver diseases are positive for anti-HBc, with some also having occult HBV infection. Among patients with AILDs, anti-HBc positivity is most common in the PBC group and in those with advanced liver fibrosis. These findings suggest a potential role of previous HBV infection in the etiology and pathogenesis of AILDs, specifically PBC.

ADVANCES IN THERAPY (2022)

Article Biochemistry & Molecular Biology

CRISPR/Cas and Hepatitis B Therapy: Technological Advances and Practical Barriers

Dmitry Kostyushev, Anastasiya Kostyusheva, Natalia Ponomareva, Sergey Brezgin, Vladimir Chulanov

Summary: After almost a decade of research, CRISPR/Cas9 technology is moving towards clinical trials for treating hepatitis B virus infections. Early studies show promising antiviral effects, but key challenges still need to be addressed to make CRISPR/Cas9 a viable therapy against HBV.

NUCLEIC ACID THERAPEUTICS (2022)

Editorial Material Endocrinology & Metabolism

Third dose of COVID-19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy

Silvia Pieralice, Luca D'Onofrio, Paolo Pozzilli, Raffaella Buzzetti

DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)

Article Endocrinology & Metabolism

Trends of glucose, lactate and ketones during anaerobic and aerobic exercise in subjects with type 1 diabetes: The ACTION-1 study

Francesca De Ridder, Kristien J. Ledeganck, Benedicte De Winter, Rie Braspenning, Danae Delbeke, Eric Renard, Paolo Pozzilli, Silvia Pieralice, Dirk Vissers, Christophe De Block

Summary: This study assessed trends in glucose, lactate, and ketones during anaerobic and aerobic exercise in individuals with type 1 diabetes (T1D) and compared the differences between the two types of exercise. It was found that omitting pre-meal insulin and basal insulin could prevent hypoglycemia but resulted in hyperglycemia due to excessive carbohydrate intake. No ketosis was observed during or after the exercises.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)

Review Endocrinology & Metabolism

C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective

Ernesto Maddaloni, Geremia B. Bolli, Brian M. Frier, Randie R. Little, Richard D. Leslie, Paolo Pozzilli, Raffaela Buzzetti

Summary: C-peptide measurement is valuable in autoimmune diabetes but limited in type 2 diabetes due to confounding factors like insulin resistance. Standardization issues exist that may affect comparability between different laboratories.

DIABETES OBESITY & METABOLISM (2022)

Article Cardiac & Cardiovascular Systems

A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes

D. Bruttomesso, C. Irace, P. Pozzilli

Summary: This study reported on glycemic control in Italian participants with type 1 diabetes and found that younger patients had better glycemic control compared to older patients. Factors such as body mass index and adherence to diet were associated with glycemic control.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2023)

Article Medicine, Research & Experimental

Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9

Dmitry Kostyushev, Anastasiya Kostyusheva, Sergey Brezgin, Natalia Ponomareva, Natalia F. Zakirova, Aleksandra Egorshina, Dmitry V. Yanvarev, Ekaterina Bayurova, Anna Sudina, Irina Goptar, Anastasiya Nikiforova, Elena Dunaeva, Tatiana Lisitsa, Ivan Abramov, Anastasiia Frolova, Alexander Lukashev, Ilya Gordeychuk, Andrey A. Zamyatnin Jr, Alexander Ivanov, Vladimir Chulanov

Summary: CRISPR-Cas9 systems show remarkable anti-HBV activity by targeting the hepatitis B virus major genomic form, cccDNA. However, inactivating cccDNA alone is not enough to cure the infection, as HBV replication rebounds due to the de novo formation of cccDNA from its precursor, rcDNA. Depleting rcDNA before delivering CRISPR-Cas9 RNPs can prevent viral rebound and promote resolution of HBV infection. These findings lay the groundwork for developing a virological cure of HBV infection using a single dose of short-lived CRISPR-Cas9 RNPs, with the help of widely used reverse transcriptase inhibitors to block cccDNA replenishment.

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

Article Computer Science, Information Systems

Layered Meta-Learning Algorithm for Predicting Adverse Events in Type 1 Diabetes

Federico D'Antoni, Lorenzo Petrosino, Alessandro Marchetti, Luca Bacco, Silvia Pieralice, Luca Vollero, Paolo Pozzilli, Vincenzo Piemonte, Mario Merone

Summary: This study proposes a layered meta-learning approach based on multi-expert systems to predict adverse events in patients with type 1 diabetes. Three deep neural networks are used to specialize in predicting hypoglycemia, hyperglycemia, or euglycemia. The outputs of the experts are then passed to a meta-learner to provide the final classification. The approach is able to predict hypoglycemia events with an average time gain of 22.8 minutes and hyperglycemia events with an average advance of 24.0 minutes.

IEEE ACCESS (2023)

Article Pharmacology & Pharmacy

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle-Mimetic Nanovesicles Loaded with Chemotherapeutics

Sergey Brezgin, Anastasiya Kostyusheva, Natalia Ponomareva, Ekaterina Bayurova, Alla Kondrashova, Anastasia Frolova, Olga Slatinskaya, Landysh Fatkhutdinova, Georgy Maksimov, Mikhail Zyuzin, Ilya Gordeychuk, Alexander Lukashev, Sergey Makarov, Alexander Ivanov, Andrey A. Zamyatnin Jr, Vladimir Chulanov, Alessandro Parodi, Dmitry Kostyushev

Summary: Biological nanoparticles, such as extracellular vesicles (EVs) and extracellular vesicle-mimetic nanovesicles (EMNVs), have been extensively studied as drug delivery vehicles in medical applications. This study investigated the properties and drug delivery abilities of EVs and EMNVs, and analyzed their use for delivering the chemotherapeutic drug doxorubicin. EMNVs were found to be more effectively internalized, while EVs showed higher intracellular release of doxorubicin.

PHARMACEUTICS (2023)

Review Endocrinology & Metabolism

Diabetes, COVID-19, and questions unsolved

Felecia D'Souza, Raffaella Buzzetti, Paolo Pozzilli

Summary: Recent evidence suggests that diabetes is associated with increased risk and adverse outcomes from COVID-19 infection. The mechanisms include dysregulation of specific enzymes and impaired immune responses, exacerbated by hyperglycemia. Limited studies on COVID-19 vaccination in people with diabetes show that vaccination is protective against adverse outcomes. People with diabetes should be prioritized in vaccination efforts and blood sugar optimization is essential in reducing their COVID-19-associated risk.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Editorial Material Endocrinology & Metabolism

What does publishing a paper mean for you?

Pozzilli Paolo

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Biochemistry & Molecular Biology

Proteolytic Resistance Determines Albumin Nanoparticle Drug Delivery Properties and Increases Cathepsin B, D, and G Expression

Ekaterina P. Kolesova, Vera S. Egorova, Anastasiia O. Syrocheva, Anastasiia S. Frolova, Dmitry Kostyushev, Anastasiia Kostyusheva, Sergey Brezgin, Daria B. Trushina, Landysh Fatkhutdinova, Mikhail Zyuzin, Polina A. Demina, Evgeny V. Khaydukov, Andrey A. Zamyatnin, Alessandro Parodi

Summary: Proteolytic activity plays a crucial role in cell homeostasis and function, with implications in cancer progression and treatment response. Endosomes, which are often the final destination of internalized nanoparticles, are major sites of cellular proteolytic activity. However, little is known about the impact of nanoparticles on endosomal biology. In this study, we generated albumin nanoparticles with varying resistance to proteolysis and demonstrated a relationship between their sensitivity to proteases and drug delivery properties, irrespective of the degree of proteolytic degradation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medicine, Research & Experimental

Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus

Dmitry Kostyushev, Sergey Brezgin, Anastasiya Kostyusheva, Natalia Ponomareva, Ekaterina Bayurova, Natalia Zakirova, Alla Kondrashova, Irina Goptar, Anastasiya Nikiforova, Anna Sudina, Yurii Babin, Ilya Gordeychuk, Alexander Lukashev, Andrey A. Zamyatnin Jr, Alexander Ivanov, Vladimir Chulanov

Summary: APOBEC/AID cytidine deaminases play an important role in innate immunity and antiviral defenses. Researchers developed a CRISPR-activation-based approach to induce APOBEC/AID overexpression and control its effects on HBV replication and cellular toxicity. The study highlights the potential for precise control of APOBEC/AID activation as a strategy for suppressing HBV replication without toxicity.

MOLECULAR THERAPY-NUCLEIC ACIDS (2023)

Review Cell Biology

Common Marmoset Cell Lines and Their Applications in Biomedical Research

Ekaterina Bayurova, Alla Zhitkevich, Daria Avdoshina, Natalya Kupriyanova, Yuliya Kolyako, Dmitry Kostyushev, Ilya Gordeychuk

Summary: Common marmosets (CMs) are small primates widely used in biomedical research, but the number of available standardized and well-defined CM cell lines derived from different tissues is still small. The main applications of CM stem cells include regenerative medicine, stem cell research, generation of transgenic CMs, transplantology, cell therapy, reproductive physiology, oncology, and neurodegenerative diseases.

CELLS (2023)

No Data Available